INHIBRX BIOSCIENCES, INC. (INBX) Operating margin 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) operating margin by fiscal year — reported operating income divided by reported revenue.
-10386.5%FY2025 · since FY2023: -12178.9% → -10386.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -10386.5% | +155337.5 pp |
| FY2024 | -165724.0% | -153545.1 pp |
| FY2023 | -12178.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INBX financial trends
INBX RevenueINBX Net incomeINBX Net marginINBX Gross profitINBX Gross marginINBX Operating incomeINBX Operating cash flowINBX Free cash flowINBX Capital expendituresINBX Return on equityINBX Stock buybacksINBX Dividends paidINBX Total assetsINBX Total liabilitiesINBX Shareholders’ equityINBX overview →